{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:07:43Z","timestamp":1793549263844,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fluorodeoxyglucose (FDG) uptake by alveolar echinococcosis (AE) liver lesions is a signal of their metabolic activity and of disease progression. In order to find a surrogate marker for this status, we investigated whether parameters of the peripheral and\/or periparasitic immune responses were associated with metabolic activity in a prospective case-control study of 30 AE patients and 22 healthy controls. Levels of 18 cytokines and chemokines, representative of innate and adaptive immune responses, were assessed in plasma and peripheral cells of two groups of patients with (MAAE) and without (MIAE) metabolically active lesions, and in the liver of MAAE patients. Mixed cytokine profile was observed in the peripheral blood of AE patients, with a predominance of Th2, Th17 and Treg responses. Among the detected markers only plasma IL-5 and IL-23, more elevated in MAAE patients, were found discriminant. Discrimination between MAAE and MIAE patients obtained by using IL-23 was improved when IL-5 was used in combination. The combination of elevated levels of IL-5 and IL-23 is significantly associated with FDG uptake at PET scan. It offers a new tool for the follow-up of AE patients which could substitute to FDG-PET whenever non-available to assess disease progression.<\/jats:p>","DOI":"10.1038\/s41598-018-20301-8","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T10:49:11Z","timestamp":1520419751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Plasma IL-23 and IL-5 as surrogate markers of lesion metabolic activity in patients with hepatic alveolar echinococcosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Tuerhongjiang","family":"Tuxun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadike","family":"Apaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Zhang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Yong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuerganaili","family":"Aji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Mei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"20301_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/QCO.0b013e32833d7516","volume":"23","author":"P Kern","year":"2010","unstructured":"Kern, P. Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 23, 505\u2013512, https:\/\/doi.org\/10.1097\/QCO.0b013e32833d7516 (2010).","journal-title":"Curr Opin Infect Dis"},{"key":"20301_CR2","doi-asserted-by":"publisher","first-page":"e3866","DOI":"10.1136\/bmj.e3866","volume":"344","author":"DP McManus","year":"2012","unstructured":"McManus, D. P., Gray, D. J., Zhang, W. & Yang, Y. Diagnosis, treatment, and management of echinococcosis. BMJ 344, e3866, https:\/\/doi.org\/10.1136\/bmj.e3866 (2012).","journal-title":"BMJ"},{"key":"20301_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.5754\/hge10545","volume":"59","author":"A Ayifuhan","year":"2012","unstructured":"Ayifuhan, A. et al. Surgical treatment for hepatic alveolar echinococcosis: report of 50 cases. Hepatogastroenterology 59, 790\u2013793, https:\/\/doi.org\/10.5754\/hge10545 (2012).","journal-title":"Hepatogastroenterology"},{"key":"20301_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1080\/14787210.2016.1240030","volume":"14","author":"DA Vuitton","year":"2016","unstructured":"Vuitton, D. A. et al. Current interventional strategy for the treatment of hepatic alveolar echinococcosis. Expert Rev Anti Infect Ther 14, 1179\u20131194, https:\/\/doi.org\/10.1080\/14787210.2016.1240030 (2016).","journal-title":"Expert Rev Anti Infect Ther"},{"key":"20301_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/ajt.13465","volume":"16","author":"H Wen","year":"2016","unstructured":"Wen, H. et al. Ex Vivo Liver Resection and Autotransplantation for End-Stage Alveolar Echinococcosis: A Case Series. Am J Transplant 16, 615\u2013624, https:\/\/doi.org\/10.1111\/ajt.13465 (2016).","journal-title":"Am J Transplant"},{"key":"20301_CR6","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1007\/s00436-015-4649-y","volume":"114","author":"H Li","year":"2015","unstructured":"Li, H. et al. Efficiency of liposomal albendazole for the treatment of the patients with complex alveolar echinococcosis: a comparative analysis of CEUS, CT, and PET\/CT. Parasitol Res 114, 4175\u20134180, https:\/\/doi.org\/10.1007\/s00436-015-4649-y (2015).","journal-title":"Parasitol Res"},{"key":"20301_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1051\/parasite\/2014063","volume":"21","author":"B Gottstein","year":"2014","unstructured":"Gottstein, B. et al. Echinococcus metacestode: in search of viability markers. Parasite 21, 63, https:\/\/doi.org\/10.1051\/parasite\/2014063 (2014).","journal-title":"Parasite"},{"key":"20301_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1051\/parasite\/2014072","volume":"21","author":"W Liu","year":"2014","unstructured":"Liu, W. et al. Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones. Parasite 21, 74, https:\/\/doi.org\/10.1051\/parasite\/2014072 (2014).","journal-title":"Parasite"},{"key":"20301_CR9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1086\/313438","volume":"29","author":"S Reuter","year":"1999","unstructured":"Reuter, S. et al. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clin Infect Dis 29, 1157\u20131163, https:\/\/doi.org\/10.1086\/313438 (1999).","journal-title":"Clin Infect Dis"},{"key":"20301_CR10","doi-asserted-by":"publisher","first-page":"895416","DOI":"10.1155\/2015\/895416","volume":"2015","author":"T Tuxun","year":"2015","unstructured":"Tuxun, T. et al. The Potential Role of Th9 Cell Related Cytokine and Transcription Factors in Patients with Hepatic Alveolar Echinococcosis. J Immunol Res 2015, 895416, https:\/\/doi.org\/10.1155\/2015\/895416 (2015).","journal-title":"J Immunol Res"},{"key":"20301_CR11","doi-asserted-by":"publisher","first-page":"e91638","DOI":"10.1371\/journal.pone.0091638","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Transcriptional profiles of cytokine\/chemokine factors of immune cell-homing to the parasitic lesions: a comprehensive one-year course study in the liver of E. multilocularis-infected mice. PLoS One 9, e91638, https:\/\/doi.org\/10.1371\/journal.pone.0091638 (2014).","journal-title":"PLoS One"},{"key":"20301_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00430-014-0331-8","volume":"203","author":"X Huang","year":"2014","unstructured":"Huang, X., Gr\u00fcner, B., Lechner, C. J., Kern, P. & Soboslay, P. T. Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease. Medical Microbiology and Immunology 203, 185 (2014).","journal-title":"Medical Microbiology and Immunology"},{"key":"20301_CR13","doi-asserted-by":"publisher","first-page":"735342","DOI":"10.1155\/2012\/735342","volume":"2012","author":"CJ Lechner","year":"2012","unstructured":"Lechner, C. J. et al. Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in Alveolar Echinococcosis patients. Clinical & Developmental Immunology 2012, 735342 (2012).","journal-title":"Clinical & Developmental Immunology"},{"key":"20301_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1046\/j.1365-2249.2000.01308.x","volume":"121","author":"V Godot","year":"2000","unstructured":"Godot, V. et al. Resistance\/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions. Clinical and experimental immunology 121, 484\u2013490 (2000).","journal-title":"Clinical and experimental immunology"},{"key":"20301_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3413\/nukmed-0139","volume":"47","author":"S Reuter","year":"2008","unstructured":"Reuter, S. et al. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Nuklearmedizin 47, 147\u2013152 (2008).","journal-title":"Nuklearmedizin"},{"key":"20301_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2967\/jnumed.112.109942","volume":"54","author":"C Caoduro","year":"2013","unstructured":"Caoduro, C. et al. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med 54, 358\u2013363, https:\/\/doi.org\/10.2967\/jnumed.112.109942 (2013).","journal-title":"J Nucl Med"},{"key":"20301_CR17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.4254\/wjh.v8.i28.1169","volume":"8","author":"M Mihmanli","year":"2016","unstructured":"Mihmanli, M. et al. Current status of diagnosis and treatment of hepatic echinococcosis. World J Hepatol 8, 1169\u20131181, https:\/\/doi.org\/10.4254\/wjh.v8.i28.1169 (2016).","journal-title":"World J Hepatol"},{"key":"20301_CR18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/cid\/ciu520","volume":"59","author":"A Chauchet","year":"2014","unstructured":"Chauchet, A. et al. Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions. Clinical Infectious Diseases 59, 1095 (2014).","journal-title":"Clinical Infectious Diseases"},{"key":"20301_CR19","first-page":"401","volume":"8","author":"V Godot","year":"1997","unstructured":"Godot, V. et al. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis. European Cytokine Network 8, 401\u2013408 (1997).","journal-title":"European Cytokine Network"},{"key":"20301_CR20","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/iai.63.5.1688-1697.1995","volume":"63","author":"DJM Sturm","year":"1995","unstructured":"Sturm, D. J. M., Gottstein, B. & P. Kern Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infection & Immunity 63, 1688 (1995).","journal-title":"Infection & Immunity"},{"key":"20301_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/pim.12292","volume":"38","author":"J Wang","year":"2016","unstructured":"Wang, J. & Gottstein, B. Immunoregulation in larval Echinococcus multilocularis infection. Parasite Immunol 38, 182\u2013192, https:\/\/doi.org\/10.1111\/pim.12292 (2016).","journal-title":"Parasite Immunol"},{"key":"20301_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12026-008-8079-0","volume":"43","author":"PG Venugopal","year":"2009","unstructured":"Venugopal, P. G., Nutman, T. B. & Semnani, R. T. Activation and regulation of toll-like receptors (TLRs) by helminth parasites. Immunol Res 43, 252\u2013263, https:\/\/doi.org\/10.1007\/s12026-008-8079-0 (2009).","journal-title":"Immunol Res"},{"key":"20301_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bjid.2015.10.011","volume":"20","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee, S., Karmakar, S. & Babu, S. P. TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review. Braz J Infect Dis 20, 193\u2013204, https:\/\/doi.org\/10.1016\/j.bjid.2015.10.011 (2016).","journal-title":"Braz J Infect Dis"},{"key":"20301_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1586\/1744666X.2015.1037286","volume":"11","author":"DS Ashour","year":"2015","unstructured":"Ashour, D. S. Toll-like receptor signaling in parasitic infections. Expert Rev Clin Immunol 11, 771\u2013780, https:\/\/doi.org\/10.1586\/1744666x.2015.1037286 (2015).","journal-title":"Expert Rev Clin Immunol"},{"key":"20301_CR25","doi-asserted-by":"publisher","first-page":"627959","DOI":"10.1155\/2014\/627959","volume":"2014","author":"Z Luo","year":"2014","unstructured":"Luo, Z., Wang, H., Wu, Y. & Sun, Z. Clinical significance of IL-23 regulating IL-17A and\/or IL-17F positive Th17 cells in chronic periodontitis. Mediators Inflamm 2014, 627959, https:\/\/doi.org\/10.1155\/2014\/627959 (2014).","journal-title":"Mediators Inflamm"},{"key":"20301_CR26","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1128\/CVI.00257-14","volume":"21","author":"R Anuradha","year":"2014","unstructured":"Anuradha, R. et al. Interleukin 1 (IL-1)- and IL-23-mediated expansion of filarial antigen-specific Th17 and Th22 cells in filarial lymphedema. Clin Vaccine Immunol 21, 960\u2013965, https:\/\/doi.org\/10.1128\/cvi.00257-14 (2014).","journal-title":"Clin Vaccine Immunol"},{"key":"20301_CR27","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.4049\/jimmunol.180.4.2486","volume":"180","author":"LI Rutitzky","year":"2008","unstructured":"Rutitzky, L. I. et al. IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17. J Immunol 180, 2486\u20132495 (2008).","journal-title":"J Immunol"},{"key":"20301_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","volume":"9","author":"E Fitch","year":"2007","unstructured":"Fitch, E., Harper, E., Skorcheva, I., Kurtz, S. E. & Blauvelt, A. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9, 461\u2013467 (2007).","journal-title":"Curr Rheumatol Rep"},{"key":"20301_CR29","doi-asserted-by":"publisher","first-page":"e0003755","DOI":"10.1371\/journal.pntd.0003755","volume":"9","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Deletion of Fibrinogen-like Protein 2 (FGL-2), a Novel CD4+\u2009CD25+\u2009Treg Effector Molecule, Leads to Improved Control of Echinococcus multilocularis Infection in Mice. PLoS Negl Trop Dis 9, e0003755, https:\/\/doi.org\/10.1371\/journal.pntd.0003755 (2015).","journal-title":"PLoS Negl Trop Dis"},{"key":"20301_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi, K. et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467, 967\u2013971, https:\/\/doi.org\/10.1038\/nature09447 (2010).","journal-title":"Nature"},{"key":"20301_CR31","first-page":"67","volume":"78","author":"DA Vuitton","year":"1989","unstructured":"Vuitton, D. A. et al. Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clinical & Experimental Immunology 78, 67 (1989).","journal-title":"Clinical & Experimental Immunology"},{"key":"20301_CR32","unstructured":"Bresson-Hadni, S., Miguet, J., Mantion, G. & Vuitton, D. Echinococcosis of the liver. In: Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition.Rodes J, Benhamou JP, Blei AT, Reichen J, Rizzetto M. (Oxford: Wiley-Blackwell, 2007)."},{"key":"20301_CR33","doi-asserted-by":"publisher","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191\u20132194, doi:https:\/\/doi.org\/10.1001\/jama.2013.281053 (2013).","DOI":"10.1001\/jama.2013.281053"},{"key":"20301_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actatropica.2009.11.001","volume":"114","author":"E Brunetti","year":"2010","unstructured":"Brunetti, E., Kern, P. & Vuitton, D. A. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 114, 1\u201316, https:\/\/doi.org\/10.1016\/j.actatropica.2009.11.001 (2010).","journal-title":"Acta Trop"},{"issue":"Suppl","key":"20301_CR35","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1016\/j.parint.2005.11.041","volume":"55","author":"P Kern","year":"2006","unstructured":"Kern, P. et al. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 55(Suppl), S283\u2013287, https:\/\/doi.org\/10.1016\/j.parint.2005.11.041 (2006).","journal-title":"Parasitol Int"},{"key":"20301_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.actatropica.2009.10.003","volume":"113","author":"X Feng","year":"2010","unstructured":"Feng, X. et al. Dot immunogold filtration assay (DIGFA) with multiple native antigens for rapid serodiagnosis of human cystic and alveolar echinococcosis. Acta Trop 113, 114\u2013120, https:\/\/doi.org\/10.1016\/j.actatropica.2009.10.003 (2010).","journal-title":"Acta Trop"},{"key":"20301_CR37","doi-asserted-by":"publisher","first-page":"632760","DOI":"10.1155\/2015\/632760","volume":"2015","author":"T Tuxun","year":"2015","unstructured":"Tuxun, T. et al. Expression of Toll-Like Receptors 2 and 4 and Related Cytokines in Patients with Hepatic Cystic and Alveolar Echinococcosis. Mediators Inflamm 2015, 632760, https:\/\/doi.org\/10.1155\/2015\/632760 (2015).","journal-title":"Mediators Inflamm"},{"key":"20301_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","volume":"127","author":"X Cheng","year":"2008","unstructured":"Cheng, X. et al. The Th17\/Treg imbalance in patients with acute coronary syndrome. Clinical Immunology 127, 89\u201397 (2008).","journal-title":"Clinical Immunology"},{"key":"20301_CR39","doi-asserted-by":"publisher","first-page":"e55379","DOI":"10.1371\/journal.pone.0055379","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang, J. et al. TGF-beta and TGF-beta\/Smad signaling in the interactions between Echinococcus multilocularis and its hosts. PLoS One 8, e55379, https:\/\/doi.org\/10.1371\/journal.pone.0055379 (2013).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20301-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:19:21Z","timestamp":1671592761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20301-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["20301"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-20301-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"21 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4417"}}